Voloridge Investment Management
BSX icon

Voloridge Investment Management’s Boston Scientific BSX Stock Holding History

Voloridge Investment Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$140M Buy
3,275,326
+2,197,217
+204% +$119M 0.59% 27
2026
Q1 		$67.7M Sell
1,078,109
-725,804
-40% -$58.1M 0.27% 95
2025
Q4 		$172M Sell
1,803,913
-805,508
-31% -$79M 0.6% 19
2025
Q3 		$255M Buy
2,609,421
+590,743
+29% +$61.2M 0.86% 12
2025
Q2 		$217M Buy
+2,018,678
New +$204M 0.8% 14
2023
Q3 		– Sell
-490,291
Closed -$26.5M – 1389
2023
Q2 		$26.5M Buy
+490,291
New +$25.6M 0.13% 228
2022
Q2 		– Sell
-265,976
Closed -$11.8M – 1434
2022
Q1 		$11.8M Buy
265,976
+141,687
+114% +$6.14M 0.07% 372
2021
Q4 		$5.28M Buy
+124,289
New +$5.22M 0.03% 705
2021
Q1 		– Sell
-1,369,526
Closed -$49.2M – 1405
2020
Q4 		$49.2M Buy
+1,369,526
New +$49.4M 0.41% 41
2020
Q3 		– Sell
-106,035
Closed -$3.72M – 1258
2020
Q2 		$3.72M Buy
106,035
+36,616
+53% +$1.32M 0.04% 431
2020
Q1 		$2.27M Sell
69,419
-367,048
-84% -$14.3M 0.07% 320
2019
Q4 		$19.7M Buy
+436,467
New +$18.3M 0.38% 45
2019
Q2 		– Sell
-115,384
Closed -$4.43M – 774
2019
Q1 		$4.43M Sell
115,384
-109,255
-49% -$4.17M 0.13% 157
2018
Q4 		$7.94M Buy
+224,639
New +$8.15M 0.36% 78
2017
Q2 		– Sell
-1,489,358
Closed -$37M – 425
2017
Q1 		$37M Buy
1,489,358
+1,273,836
+591% +$31M 0.9% 16
2016
Q4 		$4.66M Sell
215,522
-1,791,597
-89% -$39.1M 0.1% 262
2016
Q3 		$47.8M Buy
2,007,119
+1,213,310
+153% +$28.9M 1.04% 9
2016
Q2 		$18.6M Buy
+793,809
New +$17.2M 0.53% 57
2015
Q3 		– Sell
-747,784
Closed -$13.2M – 286
2015
Q2 		$13.2M Buy
+747,784
New +$13.4M 0.67% 35

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Voloridge Investment Management's BSX Position: Q2 2026 in Review

Voloridge Investment Management increased its Boston Scientific (BSX) stake by 204% in Q2 2026, buying an estimated $119M and bringing the position to 3,275,326 shares worth $140M. The position accounts for 0.59% of the portfolio, ranked #27.

Voloridge Investment Management first reported a position in BSX in Q2 2015 and has held it in 19 quarters since. The position peaked at $255M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Voloridge Investment Management held 3,275,326 shares of Boston Scientific worth $140M as of Q2 2026.
  • Voloridge Investment Management bought 2,197,217 Boston Scientific shares in Q2 2026, an estimated $119M.
  • Boston Scientific made up 0.59% of Voloridge Investment Management's portfolio in Q2 2026, its #27 holding.
  • Voloridge Investment Management first reported a position in Boston Scientific in Q2 2015 and has held it in 19 quarters since.
  • Voloridge Investment Management's Boston Scientific position peaked at $255M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.